Citations

Clear

60 citation(s) found for "Scharf, E".

Association of Anxiety and Unspecified Emotional Distress Obtained from a Medical Records Linkage System with Incident Cognitive Outcomes in a Population-Based Setting
Syrjanen, Jeremy A. , Kremers, Walter K. , Fields, Julie A. , Petersen, Ronald C. , Vassilaki, Maria , Geda, Yonas E. , Krell-Roesch, Janina, Geda, Yonas E , Kremers, Walter K , Krell‐Roesch, Janina , Scharf, Eugene , Knopman, David S.

Mayo Clinic

Journal of Alzheimer’s Disease | July 12, 2024 | Volume: 100 | Issue: 4 | Pages: 1355-1364

10.3233/jad-240213 | PMID 38995789 Get It

Background: Studies that assess cognition prospectively and study in detail anxiety history in the participants’ medical records within the context of brain aging and Alzheimer’s disease are limited. Objective: To examine the associations of anxiety and unspecified emotional distress (UED) acquired throughout a person’s life with prospectively collected cognitive outcomes. Methods: Mayo Clinic Study of Aging participants who were cognitively unimpaired at baseline were included. Anxiety and UED data were abstracted from the medical record using the Rochester Epidemiology Project (REP) resources and were run separately as predictors in our models. The data were analyzed using Cox proportional hazards models for the outcomes of incident mild cognitive impairment (MCI) and dementia and using linear mixed effects models for the outcomes of global and domain specific cognitive z-scores and included key covariates. Results: The study sample ( n = 1,808) had a mean (standard deviation) age of 74.5 (7.3) years and 51.4% were male. Anxiety was associated with increased risk of MCI and dementia and was associated with lower baseline cognitive z-scores and accelerated decline over time in the global, memory, and attention domains. UED was associated with faster decline in all domains except visuospatial but did not show evidence of association with incident cognitive outcomes. These results varied by medication use and timing of anxiety. Conclusions: Anxiety and UED both showed inverse associations with cognition. Utilization of anxiety and UED data from across the life course, as available, from the REP system adds robustness to our results.
Neuropsychiatric symptoms and risk of cognitive impairment: Mayo Clinic Study of Aging
Syrjanen, Jeremy A. , Fields, Julie A. , Petersen, Ronald C. , Vassilaki, Maria , Krell‐Roesch, Janina , Kremers, Walter K. , Scharf, Eugene , Knopman, David S. , Geda, Yonas E.

Mayo Clinic

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S18 | Pages: No page available

10.1002/alz.076424 Get It

AbstractBackgroundMost studies on the relationship between neuropsychiatric symptoms (NPS) and cognitive decline focus on NPS data collected over a short period of time. To better understand the association between NPS and cognitive decline, including their temporal relationship, it is important to know NPS status across a person’s life.MethodWe utilized the unique Rochester Epidemiology Project medical record linkage system that has captured medical records as far back as 1907, to abstract the psychiatric history of 1810 cognitively unimpaired participants in the population‐based Mayo Clinic Study of Aging (MCSA). Trained nurse abstractors ascertained the presence of exposure to three common NPS (anxiety, depression, and unspecified emotional distress [UED]), both before and after entry into the MCSA. We conducted Cox Proportional Hazards (PH) models using age as the time scale and adjusting for sex, education, and APOE E4 allele for each NPS in predicting mild cognitive impairment (MCI), or dementia. Additional analyses considering medication use (yes/no) and timing of NPS were also run.ResultAnxiety (Hazard Ratio [HR] = 1.47, p<0.001), depression (HR = 1.36, p = 0.001), and UED (HR = 1.22, p = 0.039) were associated with a higher risk of MCI. These associations were present regardless of medication use for anxiety (With medication: HR = 1.51, p<0.001; without medication: HR = 1.41, p = 0.015), and for those taking medications for depression (With medication: HR = 1.47, p<0.001; without medication: 1.09, p = 0.597). Anxiety was associated with MCI regardless of timing of onset with the strongest relationship being for those with onset of anxiety before 65 that persisted into later life (HR = 1.88, p = 0.004). Depression was associated regardless of timing of onset if the depression was present in late life too. The results were similar for the outcome of dementia (Anxiety: HR = 1.62, p<0.001; depression: HR = 1.31, p = 0.040; UED: HR = 1.37, p = 0.014). The associations accounting for medication use and timing of NPS were similar for the outcome of dementia too.ConclusionNPS is associated with progression to MCI and dementia. Both medication use and timing of NPS might play a role in these associations.
Arteriovenous Fistula Presenting as Progressive Bifrontal Intracerebral Hemorrhage (P6.209)
Cox, Benjamin C. , Johnson, Stephen A. , Scharf, Eugene

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p6.209 Get It

Zoster vasculopathy surveillance using intracranial vessel wall imaging (S45.007)
Carabenciov, Ivan D. , English, Stephen , Petty, George W., Lehman, Vance T. , Scharf, Eugene

Mayo Clinic

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.s45.007 Get It

Cardiovascular and metabolic risk factors for the development of cerebral small vessel disease: Longitudinal FLAIR imaging in the Mayo Clinic Study of Aging (P5.3-057)
Graff‐Radford, Jonathan , Przybelski, Scott A. , Preboske, Gregory M., Gunter, Jeffery, Petersen, Ronald C. , Scharf, Eugene , Knopman, David S. , Schwarz, Christopher G. , Senjem, Matthew L. , Kantarci, Kejal , Mielke, Michelle M. , Jack, Clifford R. , Vemuri, Prashanthi

Mayo Clinic

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p5.3-057 Get It

Utility of Brain MRI in Infective Endocarditis (S46.004)
Chakraborty, Tia , Abdelghani, El-Rafei, Fugate, Jennifer E. , Scharf, Eugene , DeSimone, Daniel C. , Rabinstein, Alejandro A. , Wijdicks, Eelco F. M. , Baddour, Larry M.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.s46.004 Get It

Are Serial Cerebrospinal Fluid Examinations Useful in Evaluating Hematological Malignancy in Neurological Disease? (P6.289)
Curtis, Hanson, Keegan, Mark , Scharf, Eugene

Mayo Clinic

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p6.289 Get It

Medusa Head-Type Neuronal Autoantibody Inositol Triphosphate Receptor-1 (ITPR1)-IgG: Frequency, Clinical Phenotype and Cancer Associations (P5.300)
Alfugham, Nora, Lennon, Vanda A. , Komorowski, Lars , Probst, Christian , Scharf, Madeleine, Pittock, Sean J.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p5.300 Get It

Orthostatic Hypotension and Near-Total Cervical Artery Atherosclerotic Occlusion - A Case Report (P5.123)
Chou, Claudia , Scharf, Eugene , Singer, Wolfgang

Mayo Clinic

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p5.123 Get It

Educational Intervention Reduces Utilization of Low-Value Testing in Cerebrovascular Inpatients: An Example of Rapidly Implementable Quality Improvement (P2.309)
Jones, Amy, Martinez‐Thompson, Jennifer M. , Pichler, Michael, Cohen, Alexander , Nozile-Firth, Kamilia, Scharf, Eugene , Clark, Sarah J. , Jones, Lyell K.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p2.309 Get It